Indication
E. coli gynecological infections
*Escherichia coli* gynecological infections encompass localized or ascending bacterial infections of the female reproductive tract caused by the Gram-negative bacillus *E. Read more about E. coli gynecological infections
43 drugs 29 manufacturers
Drugs that treat it
Common E. coli gynecological infections therapies.
FORTAZ (ceftazidime)
FORTAZ IN D5W (ceftazidime sodium in iso-osmotic dextrose)
UNASYN (ampicillin sodium/sulbactam sodium)
CEFTAZIDIME (ceftazidime in dextrose 5 % and water)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
TAZICEF (ceftazidime)
TAZICEF (ceftazidime)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Escherichia coli* gynecological infections encompass localized or ascending bacterial infections of the female reproductive tract caused by the Gram-negative bacillus *E.
coli*.
Affecting the female reproductive system, these conditions typically arise when pathogenic or gastrointestinal commensal strains colonize the vaginal introitus and ascend through the endocervix, often occurring in polymicrobial settings or secondary to disruption of the normal protective vaginal microbiome.
Clinically, these manifestations include endometritis, pelvic inflammatory disease, tubo-ovarian abscesses, aerobic vaginitis, and postoperative pelvic or vaginal cuff infections.
Defining features involve acute pelvic or lower abdominal pain, purulent discharge, localized tenderness, systemic signs of inflammation such as fever, and potential risks of severe suppurative sequelae or tissue necrosis.
- nih.gov
*Escherichia coli* gynecological infections encompass localized or ascending bacterial infections of the female reproductive tract caused by the Gram-negative bacillus *E. coli* Affecting the female reproductive system, these conditions typically arise when pathogenic or gastrointestinal commensal strains colonize the vaginal introitus and ascend through the endocervix, often occurring in polymicrobial settings or secondary to disruption of the normal protective vaginal microbiome
- pelvicrelief.co.uk
*Escherichia coli* gynecological infections encompass localized or ascending bacterial infections of the female reproductive tract caused by the Gram-negative bacillus *E. coli* Affecting the female reproductive system, these conditions typically arise when pathogenic or gastrointestinal commensal strains colonize the vaginal introitus and ascend through the endocervix, often occurring in polymicrobial settings or secondary to disruption of the normal protective vaginal microbiome
- nih.gov
*Escherichia coli* gynecological infections encompass localized or ascending bacterial infections of the female reproductive tract caused by the Gram-negative bacillus *E. coli* Affecting the female reproductive system, these conditions typically arise when pathogenic or gastrointestinal commensal strains colonize the vaginal introitus and ascend through the endocervix, often occurring in polymicrobial settings or secondary to disruption of the normal protective vaginal microbiome
- instalab.com
Affecting the female reproductive system, these conditions typically arise when pathogenic or gastrointestinal commensal strains colonize the vaginal introitus and ascend through the endocervix, often occurring in polymicrobial settings or secondary to disruption of the normal protective vaginal microbiome Clinically, these manifestations include endometritis, pelvic inflammatory disease, tubo-ovarian abscesses, aerobic vaginitis, and postoperative pelvic or vaginal cuff infections
- fda.gov
Clinically, these manifestations include endometritis, pelvic inflammatory disease, tubo-ovarian abscesses, aerobic vaginitis, and postoperative pelvic or vaginal cuff infections Defining features involve acute pelvic or lower abdominal pain, purulent discharge, localized tenderness, systemic signs of inflammation such as fever, and potential risks of severe suppurative sequelae or tissue necrosis
- mothertobaby.org
Defining features involve acute pelvic or lower abdominal pain, purulent discharge, localized tenderness, systemic signs of inflammation such as fever, and potential risks of severe suppurative sequelae or tissue necrosis
Personalize your experience
Follow E. coli gynecological infections and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.